BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 31807117)

  • 1. Roles of sphingosine-1-phosphate signaling in cancer.
    Wang P; Yuan Y; Lin W; Zhong H; Xu K; Qi X
    Cancer Cell Int; 2019; 19():295. PubMed ID: 31807117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting sphingosine-1-phosphate signaling for cancer therapy.
    Xie Z; Liu H; Geng M
    Sci China Life Sci; 2017 Jun; 60(6):585-600. PubMed ID: 28623546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer.
    Xu G; Yang Z; Sun Y; Dong H; Ma J
    Discov Oncol; 2021 Sep; 12(1):33. PubMed ID: 35201458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphk1/S1P/S1PR1 Signaling is Involved in the Development of Autoimmune Thyroiditis in Patients and NOD.H-2
    Han C; He X; Xia X; Guo J; Liu A; Liu X; Wang X; Li C; Peng S; Zhao W; Zhou M; Shi X; Li Y; Li Y; Shan Z; Teng W
    Thyroid; 2019 May; 29(5):700-713. PubMed ID: 30963819
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind Hyde.
    Takuwa N; Du W; Kaneko E; Okamoto Y; Yoshioka K; Takuwa Y
    Am J Cancer Res; 2011; 1(4):460-81. PubMed ID: 21984966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism.
    Kwong EK; Li X; Hylemon PB; Zhou H
    Curr Pharmacol Rep; 2017 Aug; 3():176-183. PubMed ID: 29130028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine kinase 1/sphingosine-1-phosphate (S1P)/S1P receptor axis is involved in ovarian cancer angiogenesis.
    Dai L; Liu Y; Xie L; Wu X; Qiu L; Di W
    Oncotarget; 2017 Sep; 8(43):74947-74961. PubMed ID: 29088837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System.
    Cannavo A; Liccardo D; Komici K; Corbi G; de Lucia C; Femminella GD; Elia A; Bencivenga L; Ferrara N; Koch WJ; Paolocci N; Rengo G
    Front Pharmacol; 2017; 8():556. PubMed ID: 28878674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-Phosphate: A Novel Target for Lung Disorders.
    Mohammed S; Harikumar KB
    Front Immunol; 2017; 8():296. PubMed ID: 28352271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.
    Sukocheva OA; Furuya H; Ng ML; Friedemann M; Menschikowski M; Tarasov VV; Chubarev VN; Klochkov SG; Neganova ME; Mangoni AA; Aliev G; Bishayee A
    Pharmacol Ther; 2020 Mar; 207():107464. PubMed ID: 31863815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies.
    Evangelisti C; Evangelisti C; Buontempo F; Lonetti A; Orsini E; Chiarini F; Barata JT; Pyne S; Pyne NJ; Martelli AM
    Leukemia; 2016 Nov; 30(11):2142-2151. PubMed ID: 27461062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting SphK1 as a new strategy against cancer.
    Shida D; Takabe K; Kapitonov D; Milstien S; Spiegel S
    Curr Drug Targets; 2008 Aug; 9(8):662-73. PubMed ID: 18691013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and functional roles of sphingosine kinases.
    Alemany R; van Koppen CJ; Danneberg K; Ter Braak M; Meyer Zu Heringdorf D
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Feb; 374(5-6):413-28. PubMed ID: 17242884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingolipids as mediators of inflammation and novel therapeutic target in inflammatory bowel disease.
    Sukocheva OA; Lukina E; McGowan E; Bishayee A
    Adv Protein Chem Struct Biol; 2020; 120():123-158. PubMed ID: 32085881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Sphingosine Kinase 1 and Sphingosine-1-Phosphate Axis in Hepatocellular Carcinoma.
    Maceyka M; Rohrbach T; Milstien S; Spiegel S
    Handb Exp Pharmacol; 2020; 259():3-17. PubMed ID: 31321542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival.
    Maiti A; Takabe K; Hait NC
    Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sphingosine-1-phosphate signaling in physiology and diseases.
    Takuwa Y; Okamoto Y; Yoshioka K; Takuwa N
    Biofactors; 2012; 38(5):329-37. PubMed ID: 22674845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway.
    Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W
    Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.